UPDATE 1-UK Stocks-Factors to watch on Jan 27

(Adds futures and news items)
Jan 27 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 18
points lower at 6,636 on Wednesday, according to financial bookmakers, with
futures .FFIc1 down 0.43 ahead of cash market open.

* FRESNILLO: Fresnillo Plc FRES.L forecast lower gold output for the
current year than COVID-hit 2020, mainly due to a land slip at its Noche Buena
mine in Mexico. * BREWIN DOLPHIN: Brewin Dolphin BRW.L reported an 8% jump in total funds
to a record 51.4 billion pounds in the first quarter, as markets recovered after
mass COVID-19 vaccinations and government stimulus measures. * TULLOW OIL: Tullow Oil Plc TWL.L said its lenders agreed to extend talks
about a reserve-based loan by a month beyond end-January, adding it expects its
operating cash flow to reach $500 million in 2021 if the oil price stays above
$50 a barrel. * ASTRAZENECA: AstraZeneca AZN.L Chief Executive Pascal Soriot said it is
working with Oxford University on a vaccine that will target the South African
COVID-19 variant. In another statement, he also said the European Union's late
decision to strike a contract with the drugmaker to supply COVID-19 vaccines,
months after Britain, meant the company did not have enough time to iron out
glitches in setting up production lines with external
partners. * INFLATION: British retailers reported the biggest annual fall in prices
since May this month, adding to signs of pressure on the sector since
non-essential stores had to close to the public from Jan. 5 as part of renewed
COVID lockdown measures. * GOLD: Gold traded in a narrow range as market participants awaited the
U.S. Federal Reserve's monetary policy decision and developments around a
coronavirus stimulus package in the U.S. * OIL: Oil prices climbed after industry data showed U.S. crude stockpiles
fell unexpectedly last week and China, reported its lowest daily rise in
COVID-19 cases, bolstering hopes of a pick-up in demand. * The UK blue-chip index .FTSE closed 0.2% higher on Tuesday after
AstraZeneca denied reports that its COVID-19 vaccine was less effective in the
elderly population. * For more on the factors affecting European stocks, please click on:
LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB